Adaptive Biotechnologies Corp (Adaptive) is a developer of immune-driven medicine. Its products include immunoSEQ, T-Detect, Vaccines and clonoSEQ. The company provides an immune-sequencing platform to laboratories for conducting research in the areas of oncology and other immune-mediated diseases, and TCR screening for the development of vaccines. Adaptive develops assays for both clinical diagnosis and therapeutic monitoring for a variety of disorders and conditions. It specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company translates immune-sequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. It partnered with institutions and biopharmaceutical companies. Adaptive is headquartered in Seattle, Washington, the US.
Adaptive Biotechnologies Corp premium industry data and analytics
Products and Services
Products | Services |
---|---|
immunoSEQ | Life Sciences Research |
immunoSEQ T-MAP | Drug Discovery |
clonoSEQVaccines | |
XYZ | |
XYZ | |
XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Contracts/Agreements | In November, the company announced a multi-year, global translational collaboration with BeiGene to assess minimal residual disease (MRD) using clonoSEQ assay technology. |
2022 | Contracts/Agreements | In October, the company entered into a partnership with Epic to integrate the clonoSEQ Assay into Epic’s comprehensive electronic medical record system. |
2022 | Others | In February, the company announced new data demonstrating ImmunoSEQ Technology to identify T-cell receptors associated with crohn’s disease. |
Competitor Comparison
Key Parameters | Adaptive Biotechnologies Corp | Illumina Inc | Natera Inc | 10X Genomics Inc | Krystal Biotech Inc |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Seattle | San Diego | Austin | Pleasanton | Pittsburgh |
State/Province | Washington | California | Texas | California | Pennsylvania |
No. of Employees | 709 | 10,590 | 3,282 | 1,243 | 229 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Chad Robins | Chief Executive Officer; Chairman | Executive Board | 2009 | 47 |
Tycho Peterson | Chief Financial Officer | Senior Management | 2022 | - |
Francis Lo | Chief People Officer | Senior Management | 2019 | 41 |
Harlan Robins | Chief Scientific Officer | Senior Management | 2009 | 49 |
Julie Rubinstein | President | Senior Management | 2018 | 50 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward